Efficacy of abatacept or infliximab treatment in rheumatoid arthritis patients with an inadequate response to methotrexate: Results from a 1-year double-blind, randomized, placebo-controlled trial

被引:0
|
作者
Bessette, L. [1 ]
Homik, J. [2 ]
Dougados, M. [3 ]
Keiserman, M. [4 ]
Codding, C. [5 ]
Songcharoen, S.
Berman, A. [6 ]
Nayiager, S. [7 ]
Saldate, C. [8 ]
Aranda, R. [9 ]
Becker, J. [9 ]
Li, T. [9 ]
Lin, C. [10 ]
Cornet, P. L. N. [11 ]
Schiff, M. [12 ]
机构
[1] Univ Quebec, Ctr Hosp, Ste Foy, PQ G1V 2M3, Canada
[2] Univ Alberta, Edmonton, AB, Canada
[3] Hop Cochin, F-75674 Paris, France
[4] Pontificia Univ Catolica, Sch Med, Porto Alegre, RS, Brazil
[5] Hlth Res Oklahoma, Oklahoma City, OK USA
[6] Ctr Med Privade Reumatol, San Miguel De Tucuman, Argentina
[7] St Augustines Med Ctr, Durban, South Africa
[8] Ctr Investigac Noroeste, Tijuana, Mexico
[9] Bristol Myers Squibb Co, Princeton, NJ USA
[10] Bristol Myers Squibb Co, Hopewell Jct, NY USA
[11] Bristol Myers Squibb Co, Shanghai, Peoples R China
[12] Denver Arthritis Clin, Denver, CO USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1178 / 1179
页数:2
相关论文
共 50 条
  • [31] Clinical and metabolic response to probiotic supplementation in patients with rheumatoid arthritis: a randomized, double-blind, placebo-controlled trial
    Zamani, Batol
    Golkar, Hamid R.
    Farshbaf, Shima
    Emadi-Baygi, Modjtaba
    Tajabadi-Ebrahimi, Maryam
    Jafari, Parvaneh
    Akhavan, Reyhaneh
    Taghizadeh, Mohsen
    Memarzadeh, Mohammad R.
    Asemi, Zatollah
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2016, 19 (09) : 869 - 879
  • [32] Treatment of rheumatoid arthritis with the selective costimulation modulator abatacept - Twelve-month results of a phase IIb, double-blind, randomized, placebo-controlled trial
    Kremer, JM
    Dougados, M
    Emery, P
    Durez, P
    Sibilia, J
    Shergy, W
    Steinfeld, S
    Tindall, E
    Becker, JC
    Li, T
    Nuamah, IF
    Aranda, R
    Moreland, LW
    ARTHRITIS AND RHEUMATISM, 2005, 52 (08): : 2263 - 2271
  • [33] Sarilumab plus methotrexate in patients with active rheumatoid arthritis and inadequate response to methotrexate: results of a randomized, placebo-controlled phase III trial in Japan
    Tanaka, Yoshiya
    Wada, Kazuteru
    Takahashi, Yoshinori
    Hagino, Owen
    van Hoogstraten, Hubert
    Graham, Neil M. H.
    Kameda, Hideto
    ARTHRITIS RESEARCH & THERAPY, 2019, 21 (1)
  • [34] The relationship of serum infliximab concentrations to clinical improvement in rheumatoid arthritis - Results from ATTRACT, a multicenter, randomized, double-blind, placebo-controlled trial
    Clair, EWS
    Wagner, CL
    Fasanmade, AA
    Wang, B
    Schaible, T
    Kavanaugh, A
    Keystone, EC
    ARTHRITIS AND RHEUMATISM, 2002, 46 (06): : 1451 - 1459
  • [35] Sarilumab plus methotrexate in patients with active rheumatoid arthritis and inadequate response to methotrexate: results of a randomized, placebo-controlled phase III trial in Japan
    Yoshiya Tanaka
    Kazuteru Wada
    Yoshinori Takahashi
    Owen Hagino
    Hubert van Hoogstraten
    Neil M. H. Graham
    Hideto Kameda
    Arthritis Research & Therapy, 21
  • [36] Treatment of rheumatoid arthritis with ornidazole: a randomized, double-blind, placebo-controlled study
    Ogrendik, Mesut
    RHEUMATOLOGY INTERNATIONAL, 2006, 26 (12) : 1132 - 1137
  • [37] Treatment of rheumatoid arthritis with ornidazole: a randomized, double-blind, placebo-controlled study
    Mesut Ogrendik
    Rheumatology International, 2006, 26 : 1132 - 1137
  • [38] Alefacept in combination with methotrexate for the treatment of psoriatic arthritis - Results of a randomized, double-blind, placebo-controlled study
    Mease, Philip J.
    Gladman, Dafna D.
    Keystone, Edward C.
    ARTHRITIS AND RHEUMATISM, 2006, 54 (05): : 1638 - 1645
  • [39] Efficacy of methotrexate in ankylosing spondylitis: A randomized, placebo-controlled, double-blind trial.
    Gonzalez-Lopez, L
    Garcia-Gonzalez, A
    Vazquez-del-Mercado, M
    Munoz-Valle, JF
    Gamez-Nava, JI
    ARTHRITIS AND RHEUMATISM, 2002, 46 (09): : S433 - S433
  • [40] Efficacy of the cardiac glycoside digoxin as an adjunct to csDMARDs in rheumatoid arthritis patients: a randomized, double-blind, placebo-controlled trial
    El-Mahdy, Nageh A.
    Tadros, Mariam G.
    El-Masry, Thanaa A.
    Binsaleh, Ammena Y.
    Alsubaie, Nawal
    Alrossies, Amani
    Abd Elhamid, Medhat I.
    Osman, Enas Y.
    Shalaby, Hadeel M.
    Saif, Dalia S.
    FRONTIERS IN PHARMACOLOGY, 2024, 15